288 related articles for article (PubMed ID: 31928530)
1. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression.
Yuan K; Ye J; Liu Z; Ren Y; He W; Xu J; He Y; Yuan Y
J Exp Clin Cancer Res; 2020 Jan; 39(1):9. PubMed ID: 31928530
[TBL] [Abstract][Full Text] [Related]
2. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
[TBL] [Abstract][Full Text] [Related]
3. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
[TBL] [Abstract][Full Text] [Related]
4. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
[TBL] [Abstract][Full Text] [Related]
5. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
Zhou J; Wu A; Yu X; Zhu J; Dai H
Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
Cao Y; Wang J; Tian H; Fu GH
J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
[TBL] [Abstract][Full Text] [Related]
7. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
[TBL] [Abstract][Full Text] [Related]
8. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
9. Ceramide synthase 6 predicts the prognosis of human gastric cancer: It functions as an oncoprotein by dysregulating the SOCS2/JAK2/STAT3 pathway.
Uen YH; Fang CL; Lin CC; Hseu YC; Hung ST; Sun DP; Lin KY
Mol Carcinog; 2018 Dec; 57(12):1675-1689. PubMed ID: 30129684
[TBL] [Abstract][Full Text] [Related]
10. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
[TBL] [Abstract][Full Text] [Related]
11. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
12. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LINC00165-induced by STAT3 exerts oncogenic properties via interaction with Polycomb Repressive Complex 2 to promote EMT in gastric cancer.
Jin Y; Wu P; Zhao W; Wang X; Yang J; Huo X; Chen J; De W; Yang F
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):223-230. PubMed ID: 30448060
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
Xu W; Fu J; Wu H; Sun W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
[TBL] [Abstract][Full Text] [Related]
15. [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway].
Li W; Zhao SL; Zheng P; Shi PQ; Zhou Y; Zhang T; Huo J; Yang J
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):728-736. PubMed ID: 35880339
[No Abstract] [Full Text] [Related]
16. Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer.
Jiang L; Wang WJ; Li ZW; Wang XZ
Cancer Biomark; 2017 Dec; 20(4):499-509. PubMed ID: 28869440
[TBL] [Abstract][Full Text] [Related]
17. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
18. RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling.
Liu M; Li H; Zhang H; Zhou H; Jiao T; Feng M; Na F; Sun M; Zhao M; Xue L; Xu L
Cell Death Dis; 2022 Mar; 13(3):287. PubMed ID: 35361764
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
20. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]